Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 11
Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]
Authors Samizadeh S, De Boulle K
Received 7 June 2018
Accepted for publication 7 June 2018
Published 14 December 2018 Volume 2018:11 Pages 629—630
Samizadeh S, De Boulle K. Clin Cosmet Investig Dermatol. 2018;11:273–287.
On page 273, Introduction section, line 5, the sentence “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and unaffected by D.1,4–6” should be changed to “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and almost unaffected by D.1,4–6,131”.
On page 273, Introduction section, line 11, “BoNTs” should be changed to “botulinum toxins”.
On page 276, Table 2, Storage conditions column, “Below 8°C” should be changed to “2°C–8°C”.
Read the original article
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.